The Comparison of Single Catheter and Double Catheter Adrenal Vein Sampling Methods Based on the Upper Limb Approach
NCT06737848 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2024-12-17
Summary
Primary Aldosteronism (PA) is a clinical syndrome characterized by the autonomous overproduction of aldosterone by the adrenal cortex's zona glomerulosa, leading to hypertension, elevated aldosterone levels, and suppressed renin activity as the primary manifestations. Studies have shown that the prevalence of PA in an unselected hypertensive population ranges from 5% to 11% , while the prevalence in patients with resistant hypertension is approximately 20% . PA is one of the most common causes of secondary hypertension , and its prevalence increases with rising blood pressure levels. Due to the adverse effects of PA on the heart, arterial walls, and kidneys, it contributes to the occurrence of cardiovascular events, with atrial fibrillation being the most common . In summary, PA is characterized by rapid onset, significant symptoms, obscurity, and severe complications, making early diagnosis and targeted treatment essential for prevention.
This study aims to explore a quasi-selected prospective randomized controlled method to compare the clinical efficacy differences between single-catheter and dual-catheter adrenal sampling via the right upper limb approach. The study seeks to clarify the effectiveness and safety of single-catheter sampling from the upper limb, providing a more efficient and cost-effective solution for the subtype diagnosis of patients with Primary Aldosteronism (PA).
Conditions
- Primary Aldosteronism
Interventions
- PROCEDURE
-
Single catheter adrenal vein sampling
The clinical invasive procedure involves inserting a single catheter into the right and left adrenal veins to collect blood samples from both adrenal veins.
- PROCEDURE
-
Double catheters adrenal vein sampling
The clinical invasive procedure involves inserting double catheters into the right and left adrenal veins to collect blood samples from both adrenal veins.
Sponsors & Collaborators
-
Army Medical University, China
lead OTHER
Principal Investigators
-
Li Li, MD · Army Medical University, China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-30
- Primary Completion
- 2025-04-30
- Completion
- 2025-07-31
More Related Trials
-
Adrenal Artery Ablation Treats Primary Aldosteronism
NCT03398785 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of SAAE on Ventricular Remodeling in PA Patients
NCT05501080 ·Status: RECRUITING ·Phase: NA
-
Antecubital Versus Femoral Approach for Adrenal Venous Sampling
NCT06029803 ·Status: UNKNOWN ·Phase: NA
-
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
NCT04761354 ·Status: COMPLETED
-
Outcome of Patients With Primary Aldosteronism
NCT04428827 ·Status: UNKNOWN
-
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
NCT03174847 ·Status: COMPLETED
-
Adrenal Artery Ablation for Primary Aldosteronism With Resistant Hypertension
NCT04345198 ·Status: COMPLETED ·Phase: NA
-
Adrenal Artery Ablation for Uncontrolled Hypertension
NCT03660397 ·Status: UNKNOWN ·Phase: PHASE3
-
Is the Evolution of the Aldosterone-renin Ratio Pre- Versus Post-operative on Day 1 Following Unilateral Adrenalectomy for Primary Hyperaldosteronism Predictive of Blood Pressure Outcomes
NCT07110155 ·Status: NOT_YET_RECRUITING
-
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
NCT07137364 ·Status: RECRUITING
-
Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism
NCT07328230 ·Status: RECRUITING ·Phase: NA
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study
NCT06108427 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Evaluation of Adult PHA 1 Patients
NCT00646828 ·Status: COMPLETED
-
Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA)
NCT06513676 ·Status: RECRUITING
-
The Plasma Metabolomics Profiling of Primary Aldosteronism
NCT06500000 ·Status: COMPLETED
-
Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE)
NCT07298954 ·Status: RECRUITING ·Phase: NA
-
Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment
NCT01728493 ·Status: COMPLETED
-
Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia
NCT05927961 ·Status: UNKNOWN
-
Postoperative Cardiovascular Index Change of Primary Aldosteronism
NCT00746070 ·Status: UNKNOWN
-
11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism
NCT01567111 ·Status: COMPLETED ·Phase: NA
-
Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension
NCT05430438 ·Status: COMPLETED ·Phase: NA
-
The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects
NCT01635231 ·Status: COMPLETED ·Phase: NA
-
Renal Denervation for Resistant Hypertension
NCT01865240 ·Status: TERMINATED ·Phase: PHASE4
-
Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
NCT06047912 ·Status: UNKNOWN